|

Cediranib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AZD2171

Pipeline

Phase 2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Prognostic Stage IV Breast Cancer AJCC v81
  • HER2/Neu Negative1
  • Germline BRCA2 Gene Mutation1
  • Germline BRCA1 Gene Mutation1
  • Prognostic Stage IIIC Breast Cancer AJCC v81

Houston, Texas1 trial

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.